Pharvaris NV
PHVS26.420USD
+1.280+5.09%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
1.72B시가총액
손실P/E TTM
자세한 내용은 Pharvaris NV 회사
Pharvaris NV is a Netherlands-based company primarily engaged in the biopharmaceutical industry. The Company focuses on developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema (HAE) attacks. Their key product is Deucrictibant (PHA121, PHA-022121), which is a small-molecule bradykinin B2 receptor antagonist. It is intended for both the on-demand and prophylactic treatment of HAE attacks. Deucrictibant has been studied in vitro, ex vivo, and in vivo models to assess its effectiveness in blocking the bradykinin B2 receptor. The Company is developing deucrictibant for on-demand use as PHVS416, a softgel capsule, and for prophylactic use as PHVS719, an extended-release tablet.
Pharvaris NV 정보
종목 코드 PHVS
회사 이름Pharvaris NV
상장일Feb 05, 2021
CEOModig (Berndt B.A.E)
직원 수- -
유형Ordinary Share
회계 연도 종료Feb 05
주소Emmy Noetherweg 2
도시LEIDEN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Netherlands
우편 번호2333 BK
전화31712036410
웹사이트https://pharvaris.com/
종목 코드 PHVS
상장일Feb 05, 2021
CEOModig (Berndt B.A.E)
Pharvaris NV의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Berndt Modig, CPA
Mr. Berndt Modig, CPA
Chief Executive Officer, Co-Founder, Executive Director
Chief Executive Officer, Co-Founder, Executive Director
1.48M
-26250.00%
Dr. David P. Meeker ,M.D.
Dr. David P. Meeker ,M.D.
Non-Executive Director
Non-Executive Director
102.82K
-18897.00%
Ms. Viviane Monges
Ms. Viviane Monges
Non-Executive Director
Non-Executive Director
54.91K
+23186.00%
Ms. Anna Nijdam
Ms. Anna Nijdam
Head of Finance, Principal Accounting Officer
Head of Finance, Principal Accounting Officer
50.54K
+318.00%
Dr. Elisabeth Bjork, M.D., Ph.D.
Dr. Elisabeth Bjork, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
50.53K
+28436.00%
Mr. David W. Nassif, J.D.
Mr. David W. Nassif, J.D.
Chief Financial Officer
Chief Financial Officer
800.00
+800.00%
Dr. Jochen Knolle, Ph.D.
Dr. Jochen Knolle, Ph.D.
Co-Founder, Chief Operating Officer, Chief Scientific Officer
Co-Founder, Chief Operating Officer, Chief Scientific Officer
--
--
Dr. Peng Lu, M.D., Ph.D.
Dr. Peng Lu, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Anne Lesage, Ph.D.
Dr. Anne Lesage, Ph.D.
Co-Founder, Chief Early Development Officer
Co-Founder, Chief Early Development Officer
--
--
Dr. Morgan Conn, Ph.D.
Dr. Morgan Conn, Ph.D.
Chief Business Officer
Chief Business Officer
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Berndt Modig, CPA
Mr. Berndt Modig, CPA
Chief Executive Officer, Co-Founder, Executive Director
Chief Executive Officer, Co-Founder, Executive Director
1.48M
-26250.00%
Dr. David P. Meeker ,M.D.
Dr. David P. Meeker ,M.D.
Non-Executive Director
Non-Executive Director
102.82K
-18897.00%
Ms. Viviane Monges
Ms. Viviane Monges
Non-Executive Director
Non-Executive Director
54.91K
+23186.00%
Ms. Anna Nijdam
Ms. Anna Nijdam
Head of Finance, Principal Accounting Officer
Head of Finance, Principal Accounting Officer
50.54K
+318.00%
Dr. Elisabeth Bjork, M.D., Ph.D.
Dr. Elisabeth Bjork, M.D., Ph.D.
Non-Executive Director
Non-Executive Director
50.53K
+28436.00%
Mr. David W. Nassif, J.D.
Mr. David W. Nassif, J.D.
Chief Financial Officer
Chief Financial Officer
800.00
+800.00%
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Mon, Feb 2
마지막 업데이트: Mon, Feb 2
주주
주주 유형
주주
주주
비율
General Atlantic LLC
12.54%
Fidelity Management & Research Company LLC
9.99%
Foresite Capital Management, LLC
7.46%
VenBio Partners LLC
7.24%
Viking Global Investors LP
5.70%
기타
57.07%
주주
주주
비율
General Atlantic LLC
12.54%
Fidelity Management & Research Company LLC
9.99%
Foresite Capital Management, LLC
7.46%
VenBio Partners LLC
7.24%
Viking Global Investors LP
5.70%
기타
57.07%
주주 유형
주주
비율
Private Equity
33.13%
Hedge Fund
22.83%
Investment Advisor
18.20%
Investment Advisor/Hedge Fund
9.92%
Venture Capital
6.43%
Individual Investor
5.32%
Research Firm
0.17%
Bank and Trust
0.07%
Pension Fund
0.07%
기타
3.87%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
151
61.72M
96.35%
+10.99M
2025Q3
118
49.64M
77.50%
-950.63K
2025Q2
125
52.21M
81.51%
-1.38M
2025Q1
125
53.89M
99.06%
+200.61K
2024Q4
123
53.45M
98.98%
+218.03K
2024Q3
114
53.86M
99.73%
+1.03M
2024Q2
83
52.08M
96.43%
-141.66K
2024Q1
76
49.63M
98.30%
-831.88K
2023Q4
69
47.76M
94.74%
+8.60M
2023Q3
54
36.05M
91.51%
-2.92M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
General Atlantic LLC
8.03M
12.54%
+500.00K
+6.64%
Sep 30, 2025
Fidelity Management & Research Company LLC
6.40M
9.99%
+976.76K
+18.01%
Sep 30, 2025
Foresite Capital Management, LLC
4.78M
7.46%
+368.00K
+8.34%
Sep 30, 2025
VenBio Partners LLC
4.64M
7.24%
+350.00K
+8.16%
Sep 30, 2025
Viking Global Investors LP
3.65M
5.7%
--
--
Sep 30, 2025
EQT Partners AB
3.42M
5.35%
+3.42M
--
Sep 30, 2025
Bain Capital Life Sciences Investors, LLC
3.18M
4.97%
-122.11K
-3.70%
Sep 30, 2025
Deerfield Management Company, L.P.
2.44M
3.81%
+425.00K
+21.07%
Sep 30, 2025
Commodore Capital LP
2.42M
3.78%
+507.04K
+26.53%
Sep 30, 2025
Paradigm BioCapital Advisors LP
1.84M
2.87%
+772.58K
+72.69%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
Virtus LifeSci Biotech Clinical Trials ETF
0.87%
ALPS Medical Breakthroughs ETF
0.59%
iShares MSCI Netherlands ETF
0.23%
SPDR S&P International Small Cap ETF
0.08%
iShares MSCI Europe Small-Cap ETF
0.04%
iShares MSCI EAFE Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Xtrackers MSCI Eurozone Hedged Eqty ETF
0.01%
Avantis International Small Cap Equity ETF
0%
First Trust IPOX Europe Equity Opportunities ETF
0%
더 보기
Virtus LifeSci Biotech Clinical Trials ETF
비율0.87%
ALPS Medical Breakthroughs ETF
비율0.59%
iShares MSCI Netherlands ETF
비율0.23%
SPDR S&P International Small Cap ETF
비율0.08%
iShares MSCI Europe Small-Cap ETF
비율0.04%
iShares MSCI EAFE Small-Cap ETF
비율0.02%
Fidelity Nasdaq Composite Index ETF
비율0.01%
Xtrackers MSCI Eurozone Hedged Eqty ETF
비율0.01%
Avantis International Small Cap Equity ETF
비율0%
First Trust IPOX Europe Equity Opportunities ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
